![]() |
市場調查報告書
商品編碼
2018299
美國透視市場規模、佔有率和趨勢分析報告:按類型、CPT、應用和細分市場預測(2026-2033 年)U.S. Fluoroscopy Procedures Market Size, Share & Trends Analysis Report By Type (C-Arms {including Mobile}, Fixed Table-based, Others), By CPT (50010-50437, 50500-50593, 50600-50980), By End Use (Hospitals), And Segment Forecasts, 2026 - 2033 |
||||||
據估計,美國透視市場在 2025 年的價值為 1.321 億美元,預計到 2033 年將達到 1.827 億美元,2026 年至 2033 年的複合年成長率為 4.1%。
該國先進的醫療保健基礎設施以及在診斷和治療中對醫學影像技術的嫻熟運用,支撐了這一市場的成長。
透視技術能夠實現即時X光成像,使醫生能夠在循環系統、整形外科、胃腸病學、泌尿系統和介入放射學等專科領域指導微創手術。在美國,醫院、導管檢查室和門診手術中心廣泛利用透視引導進行血管造影術、導管置入、脊椎介入和胃腸道檢查等複雜手術。對影像引導下微創治療日益成長的需求,正在強化透視技術在更廣泛的醫學影像生態系統中的作用。
影像系統的技術進步在提高透視輔助手術的效率、安全性和臨床療效方面發揮著至關重要的作用。醫院和介入影像中心正在加速從傳統透視系統向先進的數位平台過渡,這些平台能夠提高微創手術的可視性,降低輻射暴露,並簡化工作流程。美國國家醫學圖書館於2026年1月發表的一項研究評估了臨床環境中的透視系統,發現約62%的受訪透視設備目前採用平板檢測器(FPD)。與舊式影像增強管系統相比,FPD能夠提供更高的影像品質並降低輻射曝射量。研究還指出,脈衝透視功能現在幾乎已成為現代系統的標配,這反映了醫院和介入影像中心的技術升級。這些進步使得影像導引介入手術更加精準,同時提高了病患和醫護人員的輻射安全。
腎臟和泌尿系統疾病的日益普遍,對美國透視行業的成長起到了至關重要的作用。透視技術可在微創手術過程中提供即時視覺化,使醫生能夠精準地引導導管、支架和其他器械。由於慢性腎臟病和泌尿系統疾病持續影響美國相當一部分人口,醫療機構越來越依賴透視系統來支持安全有效的介入治療。根據美國疾病管制與預防中心 (CDC) 於 2024 年 5 月發布的報告《2023 年美國慢性腎臟病》,預計屆時美國將有超過七分之一的成年人(約 3550 萬人)患有慢性腎臟病,這凸顯了日益嚴重的醫療負擔。 CDC 也指出,許多患者仍未被確診,因此亟需早期發現和影像引導下的臨床介入。這種疾病的日益普及凸顯了對先進診斷和治療技術(包括用於微創腎臟和泌尿道手術的透視系統)日益成長的需求。
The U.S. fluoroscopy procedures market size was estimated at USD 132.1 million in 2025 and is expected to reach a value of USD 182.7 million in 2033, growing at a CAGR of 4.1% from 2026 to 2033. The market growth is supported by the country's advanced healthcare infrastructure and high utilization of medical imaging for both diagnostic and interventional procedures.
Fluoroscopy enables real-time X-ray imaging, allowing physicians to guide minimally invasive procedures across specialties such as cardiology, orthopedics, gastroenterology, urology, and interventional radiology. In the United States, hospitals, catheterization laboratories, and ambulatory surgical centers widely rely on fluoroscopic guidance to perform complex procedures including angiography, catheter placement, spinal interventions, and gastrointestinal examinations. The growing preference for image-guided minimally invasive treatments has strengthened the role of fluoroscopy within the broader medical imaging ecosystem.
Technological advancements in imaging systems are playing a significant role in improving the efficiency, safety, and clinical outcomes of fluoroscopy-guided procedures. Hospitals and interventional imaging centers are increasingly replacing conventional fluoroscopy systems with advanced digital platforms that offer enhanced visualization, reduced radiation exposure, and improved workflow during minimally invasive procedures. According to the study published by National Library of Medicine in January 2026 evaluating fluoroscopy systems in clinical practice found that approximately 62% of surveyed fluoroscopy units now use flat-panel detectors (FPDs), which provide improved image quality and lower radiation dose compared with older image-intensifier systems. The study also noted that pulsed fluoroscopy capabilities are now nearly universal in modern systems, reflecting technological upgrades across hospitals and interventional imaging centers. These advancements support more precise image-guided interventions while improving radiation safety for both patients and healthcare professionals.
The rising prevalence of kidney and urinary tract diseases plays critical role in the growth of U.S. fluoroscopy procedures industry. Fluoroscopy provides real-time visualization during minimally invasive procedures, allowing physicians to guide catheters, stents, and other instruments with precision. As chronic kidney disease and urinary disorders continue to affect a significant portion of the U.S. population, healthcare facilities increasingly depend on fluoroscopy systems to support safe and efficient interventions. According to the Centers for Disease Control and Prevention (CDC) report "Chronic Kidney Disease in the United States, 2023," published in May 2024, more than 1 in 7 U.S. adults (about 35.5 million people) are estimated to have chronic kidney disease, highlighting a significant and growing healthcare burden. The CDC also notes that many individuals remain undiagnosed, increasing the need for early detection and image-guided clinical interventions. This rising disease prevalence supports growing demand for advanced diagnostic and treatment technologies, including fluoroscopy systems used in minimally invasive kidney and urinary tract procedures.
U.S. Fluoroscopy Procedures Market Report Segmentation
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. fluoroscopy procedures market report based on product, application, and end use: